Author: Eichler, Madeleine; Aksi, Ebru; Pfeilschifter, Josef; Imre, Gergely
Title: Application of pseudotyped virus particles to monitor Ebola virus and SARS-CoV-2 viral entry in human cell lines Cord-id: fpdx4klo Document date: 2021_8_27
ID: fpdx4klo
Snippet: Experimental work on highly pathogenic viruses such as Ebola virus (EBOV) and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requires high-level biosafety facilities. Here we provide a detailed step-by-step protocol which details the production and application of replication-incompetent murine leukemia virus (MLV)-based pseudotyped particles to monitor and quantify the viral entry efficiency in human cell lines under bio safety level-2 conditions. We describe the use of viral parti
Document: Experimental work on highly pathogenic viruses such as Ebola virus (EBOV) and severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requires high-level biosafety facilities. Here we provide a detailed step-by-step protocol which details the production and application of replication-incompetent murine leukemia virus (MLV)-based pseudotyped particles to monitor and quantify the viral entry efficiency in human cell lines under bio safety level-2 conditions. We describe the use of viral particles encoding luciferase gene and the quantification of transduction efficiency by measuring luciferase activity.
Search related documents:
Co phrase search for related documents- acute respiratory syndrome and luciferase activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- acute respiratory syndrome and luciferase assay system: 1
- acute respiratory syndrome and luciferase gene: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- acute respiratory syndrome and luciferase measurement: 1
- acute respiratory syndrome and luciferase protein: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute respiratory syndrome and luminescence detection: 1, 2
- acute respiratory syndrome and lysis buffer: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date